Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer

Qiong Wang; Zean Li; Jin Yang; Shirong Peng; Qianghua Zhou; Kai Yao; Wenli Cai; Zhongqiu Xie; Fujun Qin; Hui Li; Xu Chen; Kaiwen Li; Hai Huang

doi:10.20892/j.issn.2095-3941.2020.0550

Article Information

vol. 19 no. 8 1193-1210

DOI

https://doi.org/10.20892/j.issn.2095-3941.2020.0550

Published By

Cancer Biology & Medicine

History

Received September 13, 2020
Accepted January 13, 2021
Published online August 29, 2022.

Article Versions

previous version (July 15, 2022 - 07:16).
You are viewing the most recent version of this article.

Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

Qiong Wang1,2,3,*,
Zean Li1,3,*,
Jin Yang3,4,
Shirong Peng1,3,
Qianghua Zhou1,3,
Kai Yao5,
Wenli Cai6,
Zhongqiu Xie2,
Fujun Qin2,
Hui Li2,
Xu Chen1,3,
Kaiwen Li1,3 ⇑ and
Hai Huang1,3,7 ⇑

¹Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
²Department of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA
³Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
⁴Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
⁵Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
⁶Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
⁷Department of Urology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan 511518, China